PGE synthase inhibitor HPGDS inhibitor 2, Purity ≥98%

Synonym: HPGDS inhibitor 2; 2101626-26-8; GSK2894631A; GSK-2894631A; 7-(Difluoromethoxy)-N-(trans-4-(2-hydroxypropan-2-yl)cyclohexyl)quinoline-3-carboxamide; 7-(Difluoromethoxy)-N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexyl]-3-quinolinecarboxamide; PGE synthase inhibitor

CAS Number: 2101626-26-8
Compound CID: 129247606

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

HPGDS inhibitor 2 is a PGE synthase inhibitor.

Molecular Weight

378.41

Molecular Formula

C₂₀H₂₄F₂N₂O₃

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Applications

HPGDS inhibitor 2 can be employed in research focused on the inhibition of hematopoietic prostaglandin D synthase (HPGDS) and its inflammatory implications.